CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 95 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,119,151 | +12.5% | 652,542 | 0.0% | 0.07% | +18.6% |
Q2 2023 | $2,773,304 | -20.0% | 652,542 | 0.0% | 0.06% | -33.0% |
Q1 2023 | $3,464,998 | -15.4% | 652,542 | 0.0% | 0.09% | -9.3% |
Q4 2022 | $4,097,964 | -40.5% | 652,542 | 0.0% | 0.10% | -37.4% |
Q3 2022 | $6,884,000 | +94.3% | 652,542 | 0.0% | 0.16% | +78.2% |
Q2 2022 | $3,543,000 | -40.9% | 652,542 | 0.0% | 0.09% | -17.1% |
Q1 2022 | $5,990,000 | -38.6% | 652,542 | 0.0% | 0.10% | -4.5% |
Q4 2021 | $9,748,000 | -55.3% | 652,542 | -31.5% | 0.11% | -50.0% |
Q3 2021 | $21,785,000 | – | 952,542 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |